TNF and leukemia: Within the positive therapeutic potential compounds, N-hydroxycinnamoylphenalkylamides (36H) are reported to have an inhibitory effect on the expression of matrix metalloproteinases- (MMP-) 9 in THP-1, a human leukemia monocytic cell line, which is stimulated by tumor necrosis factor-α (TNF-α) [7].